Two of the world's leading medtech companies have been collaborating to improve patient access to CGM technology. It now looks like Medtronic and Abbott could be close to gaining FDA clearance and moving forward to the next phase of their partnership.

For some patients, these side effects can last for years, negatively impacting their day-to-day lives. 

Two lots of Ropivacaine Hydrochloride Injection infusion bags from Amneal Pharmaceuticals are being removed from hospitals due to plastic fibers coming loose in the fluids.

Nakita Cannady, 49, was also convicted of defrauding Cigna to the tune of $194,000, billing the insurer for patient care hours her providers never filled. 

The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.

The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic hardships and rigid resource limitations. According to the Heart Rhythm Society, one way to effectively combat this issue is the development of more AFib Centers of Excellence.

Reviewing data from more than 6,000 patients, researchers found little evidence of the "obesity paradox" observed elsewhere. Underweight TAVR patients, however, may face some significant long-term risks.

“MRI images provide a better view of the anatomy of the heart and the instruments used for treatment, but also of the changes made to the treated cardiac tissue,” one cardiologist explained. “Unlike X-ray images, the entire area surrounding the heart can be seen, including the blood vessels and valves."